LPS-induced acture lung injury modell

Targeting the IRE1α-XBP1 Axis: A Novel Approach in ALI Treatment

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Targeting the IRE1α-XBP1 Axis: A Novel Approach in ALI Treatment Read More »

Global PBMC isolations, processing and analyses

Managing PBMC Complexity in Global Immuno-Oncology Trials

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Managing PBMC Complexity in Global Immuno-Oncology Trials Read More »

Customized preclinical models for rare disease drug discovery research

Pioneering Solutions in Rare Disease Research: MLM Medical Labs’ Customized Preclinical Models

Pioneering Solutions in Rare Disease Research:MLM Medical Labs’ Customized Preclinical Models by Katie Dineen, B.S., Business Development Manager Preclinical Laboratory Services  Rare diseases collectively impact over 300 million people worldwide, yet for many, effective treatments remain elusive. With more than 7,000 identified rare diseases, the challenge is not only in developing targeted therapies but also

Pioneering Solutions in Rare Disease Research: MLM Medical Labs’ Customized Preclinical Models Read More »

Obesity and 2025 Metabolic Research at MLM Medical Labs

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research by Katie Dineen, B.S., Business Development Manager Preclinical Laboratory Services Valentine’s Day is a time to celebrate love, care, and well-being—not just for each other, but also for the health of our bodies. At MLM Medical Labs, we are dedicated to supporting research

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research Read More »

Real-time clinical trial data and sample inventory

Clinical Trial Data Control plus Sample Inventory at Your Fingertips: Introducing mlm online® plus

Data Control and Sample Inventory at Your Fingertips: Introducing mlm online® and mlm online® plus In today’s fast-paced clinical trial environment, having real-time access to clinical data is not just a convenience—it’s essential. For study physicians, nurses, CROs, and sponsors, rapid and secure data access can mean the difference between staying on track and costly

Clinical Trial Data Control plus Sample Inventory at Your Fingertips: Introducing mlm online® plus Read More »

Psoriaisis Preclinical Disease Model at MLM Medical Labs

Breaking the Ice: Advancing Psoriasis Preclinical Models in Winter’s Grip

Accelerate Your Psoriasis Drug Discovery with MLM’s IL-23-Induced and IMQ-Induced Preclinical Disease Models by Katie Dineen, BS,  Business Development Manager for Pre-Clinical Research As winter sweeps across the United States with record-breaking cold temperatures, researchers studying psoriasis and related skin diseases are uniquely positioned to address the heightened challenges these conditions present. The dry, frigid

Breaking the Ice: Advancing Psoriasis Preclinical Models in Winter’s Grip Read More »

Immune Profiling through flow cytometry at MLM Medical Labs

Accelerate Your Preclinical Research with Advanced Flow Cytometry

Accelerate Your Preclinical Research with Advanced Flow Cytometry Services Unlock Cellular Insights to Propel Drug Discovery and Immunotherapy Development Why Flow Cytometry Matters in Preclinical Research and Drug Discovery Our advanced Flow Cytometry services empower researchers to gain deep insights into cellular mechanisms, evaluate drug efficacy, and ensure safety — all critical steps before advancing

Accelerate Your Preclinical Research with Advanced Flow Cytometry Read More »

Receptor Occupancy Analysis with Flow Cytometry at MLM Medical Labs

Receptor Occupancy Analysis – Powering Precision with Flow Cytometry

Receptor Occupancy Analysis Powering Precision with Flow Cytometry At MLM Medical Labs, our flow cytometry service line includes receptor occupancy analysis—a critical tool for clinical trial sponsors investigating the efficacy of immunotherapies and targeted biologics. Our expertise in this area enables accurate measurement of how well investigational drugs bind to their intended receptors, providing essential

Receptor Occupancy Analysis – Powering Precision with Flow Cytometry Read More »

MLM Medical Labs Global Gating Strategy in Flow Cytometry

How MLM’s Global Gating Strategy Elevates Your Research

How MLM’s Global Gating Strategy Elevates Your Research Unlocking Consistency in Global Clinical Trials: The Role of Flow Cytometry and Global Gating In the complex journey of drug discovery and development, consistency is key. At MLM Medical Labs, flow cytometry is a cornerstone technique for preclinical, translational, and clinical research, delivering deep insights into immune

How MLM’s Global Gating Strategy Elevates Your Research Read More »